UPCC 17221 Phase II Trial Of Xmab20717 In Patients With Advanced Biliary Tract Cancers
Enrolling By Invitation
99 years or below
All
Phase
2
27 participants needed
1 Location
Brief description of study
Please refer to Protocol Section 3.0 (Study Objectives and Endpoints). Please refer to Protocol Section 3.0 (Study Objectives and Endpoints). Please refer to Protocol Section 3.0 (Study Objectives and Endpoints).
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Medical Research
-
Age: 99 years or below
-
Gender: All
Updated on
01 Aug 2024.
Study ID: 850515
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu
For cancer trials contact EmergingMed: 1-855-216-0098 or PennCancerTrials@emergingmend.com
